Cargando…
P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
Overexpression of the MDR1 product, P-glycoprotein (Pgp), has been shown to be one of the mechanisms underlying the development of multidrug resistance (MDR). Recently, one mutant p53 has been shown to stimulate the MDR1 gene promoter in vitro, whereas wild-type p53 repressed this activity. We measu...
Autores principales: | De Angelis, P., Stokke, T., Smedshammer, L., Lothe, R. A., Lehne, G., Chen, Y., Clausen, O. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034003/ https://www.ncbi.nlm.nih.gov/pubmed/7640210 |
Ejemplares similares
-
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
por: Lehne, G., et al.
Publicado: (1996) -
Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
por: Stokke, T, et al.
Publicado: (2001) -
P‐Glycoprotein Is Positively Correlated with p53 Protein Accumulation in Human Colorectal Cancers
por: Oka, Mikio, et al.
Publicado: (1997) -
Reactivation of mutant p53 by capsaicin, the major constituent of peppers
por: Garufi, Alessia, et al.
Publicado: (2016) -
Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes
por: Angelis, P M De, et al.
Publicado: (1999)